Home
Conditions
Stage III Pancreatic Cancer

Clinical trial condition

Stage III Pancreatic Cancer

Explore clinical trials studying Stage III Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

58 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage III Pancreatic Cancer trial results

Completed

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

NCT01234935

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations: Central Hematology Oncology Medical Group, Inc. Alhambra, California, United States

TORI FULLERTON (St. Jude Heritage Healthcare Virginia K. Crosson Cancer Center) Fullerton, California, United States

Pacific Shores Medical Group Long Beach, California, United States

UCLA medical center Los Angeles, California, United States

View all 17 locations

View Trial Details

Completed

Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients

NCT00383760

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer

NCT01191684

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +28 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer

NCT01893294

Conditions: Digestive System Diseases, Digestive System Neoplasms, Duct Cell Adenocarcinoma of the Pancreas, +8 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer

NCT02307539

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors

NCT01131234

Conditions: Adenocarcinoma, Adnexal Diseases, Adult Anaplastic Astrocytoma, +120 more
Locations: Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

NCT00101348

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +122 more
Locations: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Completed

Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer

NCT00091026

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors

NCT01145456

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors

NCT00462553

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Case Western Reserve University Cleveland, Ohio, United States

View Trial Details

Stage III Pancreatic Cancer

Stage III Pancreatic Cancer trial results

Related conditions